Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Quality of life and targeted treatment for metastatic renal cell carcinoma.

× No keyword cloud information.

4 in total

1. Patient-reported outcomes in a phase iii study of everolimus versus placebo in patients with metastatic carcinoma of the kidney that has progressed on vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy.

Authors: Jennifer L Beaumont; Zeeshan Butt; Jeanfrancois Baladi; Robert J Motzer; Tomas Haas; Norbert Hollaender; Andrea Kay; David Cella
Journal: Oncologist Date: 2011-04-01

2. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors: N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal: J Natl Cancer Inst Date: 1993-03-03 Impact factor: 13.506

3. Development and validation of a scale to measure disease-related symptoms of kidney cancer.

Authors: David Cella; Susan Yount; Penny S Brucker; Hongyan Du; Ronald Bukowski; Nicholas Vogelzang; William P Bro
Journal: Value Health Date: 2007 Jul-Aug Impact factor: 5.725

4. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.

Authors: Robert J Motzer; Bernard Escudier; Stéphane Oudard; Thomas E Hutson; Camillo Porta; Sergio Bracarda; Viktor Grünwald; John A Thompson; Robert A Figlin; Norbert Hollaender; Gladys Urbanowitz; William J Berg; Andrea Kay; David Lebwohl; Alain Ravaud
Journal: Lancet Date: 2008-07-22 Impact factor: 79.321

4 in total